BACKGROUND: Circulating epithelioid cells (CECs), also known as circulating tumor, circulating cancer, circulating epithelial, or circulating nonhematologic cells, are a prognostic factor in various malignancies that can be isolated via various protocols. In the current study, the authors analyzed the cytomorphologic characteristics of CECs isolated by size in a cohort of patients with benign and malignant pancreatic diseases to determine whether cytomorphological features could predict CEC origin. METHODS: Blood samples were collected from 9 healthy controls and 171 patients with pancreatic disease who were presenting for surgical evaluation before treatment. Blood was processed with the ScreenCell size-based filtration device. Evaluable CECs were analyzed in a blinded fashion for cytomorphologic characteristics, including cellularity; nucleoli; nuclear size, irregularity, variability, and hyperchromasia; and nuclear-to-cytoplasmic ratio. Statistical differences between variables were analyzed via the Fisher exact test. RESULTS: No CECs were identified among the 9 normal healthy controls. Of the 115 patients with CECs (positive or suspicious for), 25 had nonmalignant disease and 90 had malignancy. There were no significant differences in any of the cytologic criteria noted between groups divided by benign versus malignant, neoplastic versus nonneoplastic, or pancreatic ductal adenocarcinoma versus neuroendocrine tumor. CONCLUSIONS: CECs were observed in patients with malignant and nonmalignant pancreatic disease, but not in healthy controls. There were no morphologic differences observed between cells from different pancreatic diseases, suggesting that numerous conditions may be associated with CECs in the circulation and that care must be taken not to overinterpret cells identified by cytomorphology as indicative of circulating tumor cells of pancreatic cancer. Additional studies are required to determine the origin and clinical significance of these cells. Cancer Cytopathol 2017;125:332-340.
BACKGROUND: Circulating epithelioid cells (CECs), also known as circulating tumor, circulating cancer, circulating epithelial, or circulating nonhematologic cells, are a prognostic factor in various malignancies that can be isolated via various protocols. In the current study, the authors analyzed the cytomorphologic characteristics of CECs isolated by size in a cohort of patients with benign and malignant pancreatic diseases to determine whether cytomorphological features could predict CEC origin. METHODS: Blood samples were collected from 9 healthy controls and 171 patients with pancreatic disease who were presenting for surgical evaluation before treatment. Blood was processed with the ScreenCell size-based filtration device. Evaluable CECs were analyzed in a blinded fashion for cytomorphologic characteristics, including cellularity; nucleoli; nuclear size, irregularity, variability, and hyperchromasia; and nuclear-to-cytoplasmic ratio. Statistical differences between variables were analyzed via the Fisher exact test. RESULTS: No CECs were identified among the 9 normal healthy controls. Of the 115 patients with CECs (positive or suspicious for), 25 had nonmalignant disease and 90 had malignancy. There were no significant differences in any of the cytologic criteria noted between groups divided by benign versus malignant, neoplastic versus nonneoplastic, or pancreatic ductal adenocarcinoma versus neuroendocrine tumor. CONCLUSIONS:CECs were observed in patients with malignant and nonmalignant pancreatic disease, but not in healthy controls. There were no morphologic differences observed between cells from different pancreatic diseases, suggesting that numerous conditions may be associated with CECs in the circulation and that care must be taken not to overinterpret cells identified by cytomorphology as indicative of circulating tumor cells of pancreatic cancer. Additional studies are required to determine the origin and clinical significance of these cells. Cancer Cytopathol 2017;125:332-340.
Authors: C Helissey; F Berger; P Cottu; V Diéras; L Mignot; V Servois; C Bouleuc; B Asselain; S Pelissier; I Vaucher; J Y Pierga; F C Bidard Journal: Cancer Lett Date: 2015-02-17 Impact factor: 8.679
Authors: Katherine E Poruk; Vicente Valero; Tyler Saunders; Amanda L Blackford; James F Griffin; Justin Poling; Ralph H Hruban; Robert A Anders; Joseph Herman; Lei Zheng; Zeshaan A Rasheed; Daniel A Laheru; Nita Ahuja; Matthew J Weiss; John L Cameron; Michael Goggins; Christine A Iacobuzio-Donahue; Laura D Wood; Christopher L Wolfgang Journal: Ann Surg Date: 2016-12 Impact factor: 12.969
Authors: Birte Kulemann; Martha B Pitman; Andrew S Liss; Nakul Valsangkar; Carlos Fernández-Del Castillo; Keith D Lillemoe; Jens Hoeppner; Mari Mino-Kenudson; Andrew L Warshaw; Sarah P Thayer Journal: Pancreas Date: 2015-05 Impact factor: 3.327
Authors: Ju Dong Yang; Michael B Campion; Minetta C Liu; Roongruedee Chaiteerakij; Nasra H Giama; Hager Ahmed Mohammed; Xiaodan Zhang; Chunling Hu; Victoria L Campion; Jin Jen; Sudhakar K Venkatesh; Kevin C Halling; Benjamin R Kipp; Lewis R Roberts Journal: Hepatology Date: 2015-08-07 Impact factor: 17.425
Authors: Martha B Pitman; Barbara A Centeno; Syed Z Ali; Muriel Genevay; Ed Stelow; Mari Mino-Kenudson; Carlos Fernandez-del Castillo; C Max Schmidt; William Brugge; Lester Layfield Journal: Diagn Cytopathol Date: 2014-02-19 Impact factor: 1.582
Authors: F Farace; C Massard; N Vimond; F Drusch; N Jacques; F Billiot; A Laplanche; A Chauchereau; L Lacroix; D Planchard; S Le Moulec; F André; K Fizazi; J C Soria; P Vielh Journal: Br J Cancer Date: 2011-08-09 Impact factor: 7.640
Authors: A Fatih Sarioglu; Nicola Aceto; Nikola Kojic; Maria C Donaldson; Mahnaz Zeinali; Bashar Hamza; Amanda Engstrom; Huili Zhu; Tilak K Sundaresan; David T Miyamoto; Xi Luo; Aditya Bardia; Ben S Wittner; Sridhar Ramaswamy; Toshi Shioda; David T Ting; Shannon L Stott; Ravi Kapur; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner Journal: Nat Methods Date: 2015-05-18 Impact factor: 28.547
Authors: Jens G Lohr; Viktor A Adalsteinsson; Kristian Cibulskis; Atish D Choudhury; Mara Rosenberg; Peter Cruz-Gordillo; Joshua M Francis; Cheng-Zhong Zhang; Alex K Shalek; Rahul Satija; John J Trombetta; Diana Lu; Naren Tallapragada; Narmin Tahirova; Sora Kim; Brendan Blumenstiel; Carrie Sougnez; Alarice Lowe; Bang Wong; Daniel Auclair; Eliezer M Van Allen; Mari Nakabayashi; Rosina T Lis; Gwo-Shu M Lee; Tiantian Li; Matthew S Chabot; Amy Ly; Mary-Ellen Taplin; Thomas E Clancy; Massimo Loda; Aviv Regev; Matthew Meyerson; William C Hahn; Philip W Kantoff; Todd R Golub; Gad Getz; Jesse S Boehm; J Christopher Love Journal: Nat Biotechnol Date: 2014-04-20 Impact factor: 54.908
Authors: Caroline Vilhav; Cecilia Engström; Peter Naredi; Ann Novotny; Johan Bourghardt-Fagman; Britt-Marie Iresjö; Annika G Asting; Kent Lundholm Journal: Oncol Lett Date: 2018-09-12 Impact factor: 2.967
Authors: Richard A Jacobson; Emily Munding; Dana M Hayden; Mia Levy; Timothy M Kuzel; Sam G Pappas; Ashiq Masood Journal: Cancers (Basel) Date: 2019-08-13 Impact factor: 6.639
Authors: Lauren Brady; Brian Hayes; Gráinne Sheill; Anne-Marie Baird; Emer Guinan; Bryan Stanfill; Tatjana Vlajnic; Orla Casey; Verena Murphy; John Greene; Emma H Allott; Juliette Hussey; Fidelma Cahill; Mieke Van Hemelrijck; Nicola Peat; Lorelei Mucci; Moya Cunningham; Liam Grogan; Thomas Lynch; Rustom P Manecksha; John McCaffrey; Dearbhaile O'Donnell; Orla Sheils; John O'Leary; Sarah Rudman; Ray McDermott; Stephen Finn Journal: PLoS One Date: 2020-12-18 Impact factor: 3.240